MARKET WIRE NEWS

John Hancock Disciplined Value Fund Q4 2024 Commentary

Source: SeekingAlpha

2025-02-28 07:10:00 ET

Summary

  • The John Hancock Disciplined Value Fund, while posting a narrow loss, outperformed the benchmark.
  • The fund also outpaced the index in 2024, marking the fourth consecutive year in which it has done so.
  • The Russell 1000 Value Index—the fund’s benchmark—produced a negative return in the fourth quarter.
  • Stock selection and sector allocations both contributed to the fund’s advantage in the quarter.

Average annual total returns 2 %

Qtd

Ytd

1 yr

3 yr

5 yr

10 yr

Life of fund

Life of fund date

Class I without sales charge

-0.98

15.37

15.37

7.87

10.67

9.04

9.04

1/2/97

Class A without sales charge

-1.01

15.09

15.09

7.60

10.39

8.77

8.70

1/16/97

Class A with sales charge

(Maximum initial sales charge

5.00%)

-5.96

9.35

9.35

5.77

9.27

8.22

8.50

1/16/97

Russell 1000 Value Index

-1.98

14.37

14.37

5.63

8.68

8.49

8.54

Large value category

-1.53

14.16

14.16

6.25

9.20

8.51

Expense ratios 3

Gross

Net Gross(what you pay)

Contractual through

Class I

0.78%

0.77%

7/31/2026

Class A

1.03%

1.02%

7/31/2026

Read the full article on Seeking Alpha

For further details see:

John Hancock Disciplined Value Fund Q4 2024 Commentary
AbbVie Inc.

NASDAQ: ABBV

ABBV Trading

2.61% G/L:

$229.18 Last:

2,858,492 Volume:

$227.37 Open:

mwn-app Ad 300

ABBV Latest News

ABBV Stock Data

$396,361,630,803
1,749,710,786
N/A
2503
N/A
Pharmaceuticals
Healthcare
US
North Chicago

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App